Insider Buying: Bonk (NASDAQ:BNKK) Director Buys $10,890.00 in Stock

Bonk, Inc. (NASDAQ:BNKK) Director Mitchell Austin Rudy purchased 9,000 shares of the firm’s stock in a transaction that occurred on Monday, July 13th. The shares were bought at an average cost of $1.21 per share, with a total value of $10,890.00. Following the completion of the acquisition, the director owned 95,000 shares of the company’s stock, valued at approximately $114,950. This trade represents a 10.47% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Mitchell Austin Rudy also recently made the following trade(s):

• On Friday, July 10th, Mitchell Austin Rudy acquired 1,000 shares of Bonk stock. The stock was purchased at an average price of $1.21 per share, for a total transaction of $1,210.00.
• On Thursday, July 2nd, Mitchell Austin Rudy acquired 11,659 shares of Bonk stock. The stock was purchased at an average cost of $1.47 per share, for a total transaction of $17,138.73.
• On Monday, June 22nd, Mitchell Austin Rudy acquired 7,500 shares of Bonk stock. The shares were purchased at an average price of $1.56 per share, with a total value of $11,700.00.
• On Tuesday, June 16th, Mitchell Austin Rudy bought 2,500 shares of Bonk stock. The stock was purchased at an average price of $1.32 per share, with a total value of $3,300.00.
• On Wednesday, June 10th, Mitchell Austin Rudy bought 12,000 shares of Bonk stock. The stock was purchased at an average cost of $1.37 per share, for a total transaction of $16,440.00.

Bonk Stock Down 3.8%

Shares of Bonk stock opened at $1.25 on Friday. Bonk, Inc. has a 52-week low of $1.14 and a 52-week high of $46.90. The company’s 50-day simple moving average is $1.65 and its 200-day simple moving average is $2.67. The firm has a market cap of $10 million, a price-to-earnings ratio of -0.27 and a beta of 1.89.

Bonk (NASDAQ:BNKK) last announced its quarterly earnings data on Wednesday, May 13th. The company reported ($0.23) EPS for the quarter. Bonk had a negative net margin of 838.37% and a negative return on equity of 148.62%. The firm had revenue of $0.79 million during the quarter.

Institutional Trading of Bonk

A number of institutional investors have recently modified their holdings of BNKK. State Street Corp purchased a new position in Bonk in the fourth quarter valued at approximately $33,000. Steward Partners Investment Advisory LLC purchased a new stake in Bonk during the fourth quarter worth approximately $37,000. Jane Street Group LLC acquired a new stake in shares of Bonk in the fourth quarter worth $96,000. Finally, Geode Capital Management LLC acquired a new stake in shares of Bonk in the fourth quarter worth $128,000. Hedge funds and other institutional investors own 12.55% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms recently weighed in on BNKK. Weiss Ratings cut Bonk from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, April 29th. Wall Street Zen raised shares of Bonk from a “sell” rating to a “hold” rating in a research note on Saturday, July 4th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, Bonk has an average rating of “Sell”.

About Bonk

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.